Skip to main content
. 2022 Mar 26;14(4):705. doi: 10.3390/pharmaceutics14040705

Figure 11.

Figure 11

Antimicrobial effect of C1 and C2 nanocomposites at C. albicans in vitro. C1: GO-MNPs-VGLPEGDA- ZnMintPc, C2: MWCNT-MNPs-VGLPEGDA- ZnMintPc, C3: GO-MNPs-VGLPEGDA, C4: MWCNT-MNPs-VGLPEGDA. The concentration of MNPs in C1, C2, C3 and C4 was 93.3 μg·mL−1. The concentration of ZnMintPc in C1 and C2 was 8.1 μM. The concentration of GO in C1 and C3 was 3.47 μg·mL−1. The concentration of MWCNTs in C2 and C4 was 3.47 μg·mL−1.